Minority Representation in Migraine Treatment Trials. - Wikidata - awgldk - TriplyDB

Minority Representation in Migraine Treatment Trials.

Minority Representation in Migraine Treatment Trials.

http://www.wikidata.org/entity/Q30238764

about

Do racial/ethnic disparities exist in recommended migraine treatments in US ambulatory care?

P2860

Q38709363-3F82EC36-E519-4F29-81BE-B5FA6794DB39

P2860

Minority Representation in Migraine Treatment Trials.

http://www.wikidata.org/entity/Q30238764

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Minority Representation in Migraine Treatment Trials.

@ast

Minority Representation in Migraine Treatment Trials.

@en

type

label

Minority Representation in Migraine Treatment Trials.

@ast

Minority Representation in Migraine Treatment Trials.

@en

prefLabel

Minority Representation in Migraine Treatment Trials.

@ast

Minority Representation in Migraine Treatment Trials.

@en

P1433

Q30238764-A5878194-E10A-468F-B257-DCB9B2EBE7F7

P1476

Q30238764-62175EAD-C3FC-4770-A29C-FF0D1041CCC6

P2093

Q30238764-BE9103E1-873F-482F-9214-21F66E829C4B

Q30238764-C90ADC42-116D-4C46-BEB4-171B483F8A2C

P2860

Q30238764-002D064A-A10A-4327-ADE5-CA0B2BE13837

Q30238764-031EEF53-BCD1-4272-B2AF-F9368BA46CC4

Q30238764-03638201-3469-49C2-B983-571BC9D6DFAB

Q30238764-038F3A03-DCEA-4FE7-8252-388B81D5FB5F

Q30238764-0429314C-6CDE-4B13-B810-685C7D80FCFD

Q30238764-04E68149-AD5F-446C-B064-A0B5AD457ED2

Q30238764-06C3417B-4258-43BF-A803-FAE57E9B6A8C

Q30238764-08952C1C-F586-4105-96F7-39DB3E22AECB

Q30238764-0ADC484A-FEC9-4A2C-A4E4-0B5468CCEB16

Q30238764-0DD6560C-FE83-4FE3-BA20-CAD6B0CA9F4C

P304

Q30238764-5DE0F187-AEEC-4A2B-8120-9640034D983D

P31

Q30238764-B2116DF4-B190-433C-A31B-089D9722DEDC

P356

Q30238764-A10F4466-3E9E-4BDF-8C94-C886A2E7A81C

P433

Q30238764-5AFE67EE-D48E-404F-94A1-65BC2ED507B4

P478

Q30238764-22421487-2439-4260-9305-BD69CA6F52F5

P577

Q30238764-58E827FD-9847-49A7-989C-0A3185A827D7

P698

Q30238764-BF4360F3-FC82-475B-86B2-5897F81C970D

P921

Q30238764-2896945D-00B8-459A-810F-0AF0CEFE837E

P356

P1433

P1476

Minority Representation in Migraine Treatment Trials.

@en

P2093

James L Bernat

http://www.w3.org/2001/XMLSchema#string

Nathaniel M Robbins

http://www.w3.org/2001/XMLSchema#string

P2860

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine

Are racial and ethnic minorities less willing to participate in health research?

Characterizing Race/Ethnicity and Genetic Ancestry for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort

Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical tr

Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities

Biological races in humans

Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.

Lower use of carotid artery imaging at minority-serving hospitals.

Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.

P304

525-533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HEAD.13018

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28127754

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder